01011.HK
China NT Pharma Group Company Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 0.25
−7.55%Sep 28, 2026, 01:42 UTC
Teligent Pharma engaged a legal team to commence statutory proceedings to set aside the arbitral award issued by the China International Economic and Trade Arbitration Commission.
Source:Sep 28, 2026, 01:42 UTC
China International Economic and Trade Arbitration Commission ruled that Teligent Pharma and other jointly liable parties must pay about RMB 75 million in penalties, fees and arbitration costs over breaches of warranties in a 2020 asset transaction.
Source:Aug 25, 2026, 02:07 UTC
Zhongke Tianyuan issued a profit warning, expecting its attributable loss for the six months ending June 2026 to narrow to approximately RMB 3.72 million from RMB 7.85 million a year earlier.
Source:Aug 20, 2026, 17:01 UTC
Tailing Medicine reported interim results for the six months ended June 2026, with revenue up 97.3% year-on-year to RMB 23.67 million and net loss widening to RMB 18.43 million from RMB 16.91 million a year earlier.
Source:Aug 19, 2026, 01:51 UTC
China International Economic and Trade Arbitration Commission ruled that Techlink Medical and related parties must pay about 92 million yuan in penalties and fees, and Techlink Medical has initiated legal procedures to apply for revocation of the award.
Source: